Haplotype Labs
Haplotype Labs is a healthcare diagnostics company based in Orinda, CA, offering a SaaS platform aimed at enhancing human healthspan by improving genetic testing technologies.
Services
Haplotype Labs provides a SaaS platform targeted towards genetic testing labs, concierge medical practices, and payer/providers. The platform features disease risk prediction based on genetic models, secure hosting and management of genetic data, and capabilities for generating detailed reports and running common inference algorithms without the need for custom code. This service aims to reduce sequencing costs by 50% - 90% and accelerates timelines by eliminating bespoke software pipelines.
Founders
Haplotype Labs was founded in 2024 with the mission of improving human healthspan. The company's focus is on enhancing the security, accessibility, and sophistication of population genetics software and polygenic risk scores. As a new entity in the healthcare diagnostics sector, specific information about the individual founders is not provided.
Industry and Sub-industry
Haplotype Labs operates within the healthcare industry, specifically focusing on diagnostics. The company leverages advancements in population genetics software and polygenic risk models to predict, detect, and prevent diseases. By improving the security and accessibility of genetic data, the company aims to make significant contributions to the healthcare diagnostics sub-industry.
Y Combinator Batch W24
Haplotype Labs is part of the Winter 2024 batch of Y Combinator, a notable startup accelerator. This affiliation provides the company with access to a wide network of resources, mentorship, and funding opportunities, aiding in their mission to advance population genetics software and polygenic risk scores.
Regions of Operation
Haplotype Labs offers its services primarily in the United States, Canada, and remotely. By providing a fully remote platform, the company ensures accessibility to a wide range of clients, irrespective of their geographical location. This approach supports the company's goal of enhancing the accessibility and security of genetic data on a global scale.